Patients with the ability to comprehend and willingness to participate in the trial‎. Patients who are at least 18 years old at the beginning of trial. Patients with Fever higher than 37.8 C, Cough, shortness of breath accompanied by SpO2 ≤%93, who ‎have a confirmed diagnosis of SARS-CoV-2 infection using RT-PCR. patients with increased level of TNF-alpha to 3 times as much as normal range or with remarkable increase in CRP or Ferritin.

Patients with the ability to comprehend and willingness to participate in the trial‎. Patients who are at least 18 years old at the beginning of trial. Patients with Fever higher than 37.8 C, Cough, shortness of breath accompanied by SpO2 ≤%93, who ‎have a confirmed diagnosis of SARS-CoV-2 infection using RT-PCR. patients with increased level of TNF-alpha to 3 times as much as normal range or with remarkable increase in CRP or Ferritin.